US Pharmaceutical Market Outlook 2021: CDMO Deal Making in a Pandemic and Beyond

This live panel was broadcasted on July 26 

This panel discussion will be led by Global Business Reports, alongside contributors to their 2021 US Biopharmaceuticals Report.   

With all eyes on science and pharma for solutions and treatments for COVID-19, 2020 was a colossal year for the industry. Thanks to unprecedented levels of collaboration, vaccines and therapeutics have been approved at record speeds. 

Amidst a global pandemic, CDMOs were active in making acquisitions and investments. Our expert panellists discuss those deals, the challenges closing them and reflect on their relation to some of the broader themes and future trends for the US Pharmaceutical market.   

Attendees will receive an interactive download of the 2021 US Biopharmaceuticals Report by GBR 

In Partnership with GBR